About: Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.29 (-9.49%)
LRMR NASDAQ Larimar Therapeutics Inc
Loading watchlist status…
Larimar Therapeutics Inc share price
LRMR price activity
Last Price
$2.290
Change (24hr)
-0.24 USD (-9.49%)
Volume
651.39K
Volume (4w avg)
-
Open
$2.53
Day Range
$2.29 - $2.53
Previous Close
$2.53
Last Trade
13 Oct, 4:22 pm GMT+0
Delayed
13 Oct, 4:22 pm GMT+0
LRMR price performance
-17.63%
5D
-41.58%
1M
-39.9%
YTD
-46.12%
1Y
Delayed
13 Oct, 4:22 pm GMT+0
LRMR Market Signals